Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - August 2017

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Desmopressin (Noqdirna®) has been accepted for restricted in the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults. The restriction limits use to adults aged 65 years and over.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - August 2017' on Email Share 'SMC Update - August 2017' on Delicious Share 'SMC Update - August 2017' on Digg Share 'SMC Update - August 2017' on Facebook Share 'SMC Update - August 2017' on Google+ Share 'SMC Update - August 2017' on reddit Share 'SMC Update - August 2017' on StumbleUpon Share 'SMC Update - August 2017' on Twitter

atomic-wealth

No Comments to “SMC Update - August 2017”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,521 spam comments.

atomic-wealth
fond-illness
summer